SCHEMBL2686332

SCHEMBL2686332

CN1CCN(C(C(=O)Nc2ccc(Cl)cc2)c2ccc(C(=O)O)s2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
ADRB2 P07550 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
TP53 P04637 2/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CNR1 P21554 1/20 0.43
LMNA P02545 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
EP300 Q09472 1/20 0.41
TSHR P16473 1/20 0.40
RAB9A P51151 1/20 0.39
FFAR2 O15552 1/20 0.39
IDO1 P14902 1/20 0.39
TDO2 P48775 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5586364 0.85 ADRB2 (0.47) ALDH1A1ADRB2NPSR1SMN1; SMN2TP53
SCHEMBL2686534 0.85 NPSR1 (0.46) ALDH1A1ADRB2NPSR1SMN1; SMN2TP53
SCHEMBL2686962 0.76 HDAC1 (0.49) CNR1CYP1A2CYP2C19
SCHEMBL14781042 0.76 HDAC1 (0.49) CNR1CYP1A2CYP2C19
SCHEMBL2686544 0.75 KCNH2 (0.57)
SCHEMBL5547519 0.75 ADRB2 (0.60) ALDH1A1ADRB2NPSR1SMN1; SMN2TP53
SCHEMBL2686264 0.70 ADRB2 (0.53) ALDH1A1ADRB2NPSR1SMN1; SMN2TP53
SCHEMBL2685019 0.67 HDAC1 (0.53) ALDH1A1ADRB2NPSR1SMN1; SMN2CYP1A2
SCHEMBL13234926 0.66 LMNA (0.67) ALDH1A1SMN1; SMN2TP53MEN1KMT2A
SCHEMBL2685263 0.66 MAPT (0.53) ALDH1A1NPSR1SMN1; SMN2TP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1991226-B1 INHIBITORS OF HISTONE DEACETYLASE MERCK SHARP & DOHME (US) 2013-03-20 EP disclosed
EP-1991226-B1 INHIBITORS OF HISTONE DEACETYLASE MERCK SHARP & DOHME (US) 2013-03-20 EP disclosed
US-8168658-B2 Inhibitors of histone deacetylase MERCK SHARP & DOHME CORP. (US) 2012-05-01 US disclosed
US-8168658-B2 Inhibitors of histone deacetylase MERCK SHARP & DOHME CORP. (US) 2012-05-01 US disclosed
US-8168658-B2 Inhibitors of histone deacetylase MERCK SHARP & DOHME CORP. (US) 2012-05-01 US disclosed
US-20090069250-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME LLC 2009-03-12 US disclosed
US-20090069250-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME LLC 2009-03-12 US disclosed
US-20090069250-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME LLC 2009-03-12 US disclosed
EP-1991226-A2 INHIBITORS OF HISTONE DEACETYLASE Merck & Co., Inc. (US) 2008-11-19 EP disclosed
WO-2007100657-A2 INHIBITORS OF HISTONE DEACETYLASE MERCK & CO., INC. (US) 2007-09-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069250-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC6 ALDH1A1 904/4885ADRB2 4188/4885NPSR1 2991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.